tirzepatide and antihistamine Oral Tirzepatide for Weight Loss |

20 Patients 18 Shipped $6k Revenue Monthly revenue trend What This Program Can Earn Monthly Revenue $10,500 Annual Revenue $126,000 Based on $350/mo avg revenue per patient GLP-1 weight loss is a high-demand, recurring revenue program

Weeks of suboptimal results from degraded medication represent wasted time

The activins and their binding protein, follistatindiagnostic and therapeutic targets in inflammatory disease and fibrosis

Hair loss was not reported in clinical trials for either drug and, thus, not listed in their respective PIs

Emerging treatments like ketamine therapy and psychedelics

And on top of that, the FDA requires that all of those processes be finalized before clinical trials even begin